AAAAAA

   
Results: 1-4 |
Results: 4

Authors: Weis, S King, B Thompson, SF Shaffer, N Jones, B Puentes, S Silva, C Hershfield, E Izon, G Mangura, B Reichman, L Leus, MC Owens, M Lahart, C Nickson, R Scott, T Awe, R Murphy, AL Weiner, M Engle, M Chaisson, R Sterling, T Hackman, J Wilcox, F Wassler, P Dukes-Hamilton, C Mosher, A Ho, B Reves, R Burman, W Peloquin, C Tapy, J Rom, W Condos, R Sandman, L Bhattacharya, M Fabre, J El-Sadr, W Klein, M Horton, J Quinn, E Pachuki, C Samuel, M Gordin, F Benator, D Sepulveda, D Quinlan-Mauzy, C Kernodle, D McKee, GS Reeves-Hammock, L Bernardo, J Horsburgh, CR Saukkonen, J Murphy, C Schluger, N Burzynski, J Lozano, V Menzies, R Schwartzman, K Pelletier, M Valiquette, C Nolan, C Goldberg, S Stone, M Fitzgerald, M Hernandez, E Peyvandi, B Daley, C Hopewell, P Stanton, B Merrifield, C Donovan, C Hobbs, B Gotting, V Therrien, M Ferrell, S Bozeman, L Broadnax, S Carter, C Dansbury, K Gross, L Henderson, C Jackson, M Khan, A O'Brien, R Sharma, A Villarino, ME Wang, YC Cooksey, R Crawford, J Sikes, D Metchock, B Sheppard, J Woodley, C Jaffe, H Neaton, J Bass, J
Citation: S. Weis et al., The tuberculosis trials consortium: A model for clinical trials collaborations, PUBL HEA RE, 116, 2001, pp. 41-49

Authors: Gordin, F Chaisson, RE Matts, JP Miller, C Garcia, MD Hafner, R Valdespino, JL Coberly, J Schechter, M Klukowicz, AJ Barry, MA O'Brien, RJ
Citation: F. Gordin et al., Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons - An international randomized trial, J AM MED A, 283(11), 2000, pp. 1445-1450

Authors: El-Sadr, WM Burman, WJ Grant, LB Matts, JP Hafner, R Crane, L Zeh, D Gallagher, B Mannheimer, SB Martinez, A Gordin, F
Citation: Wm. El-sadr et al., Discontinuation of prophylaxis against Mycobacterium avium complex diseasein HIV-infected patients who have a response to antiretroviral therapy., N ENG J MED, 342(15), 2000, pp. 1085-1092

Authors: Birx, DL Loomis-Price, LD Aronson, N Brundage, J Davis, C Deyton, L Garner, R Gordin, F Henry, D Holloway, W Kerkering, T Luskin-Hawk, R McNeil, J Michael, N Pierce, PF Poretz, D Ratto-Kim, S Renzullo, P Ruiz, N Sitz, K Smith, G Tacket, C Thompson, M Tramont, E Yangco, B Yarrish, R Redfield, RR
Citation: Dl. Birx et al., Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers, J INFEC DIS, 181(3), 2000, pp. 881-889
Risultati: 1-4 |